Insider · CIK 0002136365
Nishant C Saxena
Files at CRBP (Corbus Pharmaceuticals Holdings, Inc.). First filing Jun 3, 2026, latest Aug 12, 2026.
In brief
Nishant C Saxena files SEC Form 4 as officer at CRBP (Corbus Pharmaceuticals Holdings, Inc.). Since Jun 3, 2026, Nishant C Saxena has reported 2 open-market buys worth $126k and 0 open-market sells worth $0, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Nishant C Saxena has 0, so none is measured yet.
The newest scored trade: bought $25k of CRBP on Aug 11, 2026, filed Aug 12, 2026, scored 33 (weak). In the last 12 months: 2 buys worth $126k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRBP: Corbus Pharmaceuticals Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | CRBPbuy Corbus Pharmaceuticals Holdings, Inc. | $25k 2,600 shares | +3% | +29% from low-51% from high | |
| 49Moderate | CRBPbuy Corbus Pharmaceuticals Holdings, Inc. | $101k 13,500 shares | +22% | +9% from low-61% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +2,600 | $9.63 | $25k | 77,900 | Aug 12, 2026 |
| Jun 2, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +4,500 | $7.33 | $33k | 66,300 | Jun 3, 2026 |
| Jun 3, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +9,000 | $7.58 | $68k | 75,300 | Jun 3, 2026 |
| May 21, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share | +58,300 | $0.00 | $0 | 61,800 | May 22, 2026 |
| May 21, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock options (right to buy)derivative | +192,300 | $0.00 | $0 | 192,300 | May 22, 2026 |
Questions about Nishant C Saxena
Answered from the filings on this page, as of the latest one.
Is Nishant C Saxena buying or selling?
In the last 12 months Nishant C Saxena reported 2 open-market buys worth $126k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of CRBP on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Nishant C Saxena's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nishant C Saxena has 0.
Where does Nishant C Saxena file Form 4?
Nishant C Saxena has filed Form 4 at CRBP (Corbus Pharmaceuticals Holdings, Inc.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.